Skip to main content
eLearning on BoehringerOne

Linagliptin: 10 Years of Simplicity

Presenters

Dr. Richard Russell
Clinician scientist and program leader
Prof. Merlin Thomas
Dr. Richard Russell
Inaugural Head, Department of Diabetes
Prof. Mark Cooper
  • 47 mins

  • Self paced

    Upon completion you will earn a certificate.

The aim of this webinar is to provide updates on how Linagliptin has brought improvements in diabetes care over the last 10 years. It will discuss the clinical trials of linagliptin – its efficacy, cardiovascular and renal safety and convenience across a broad range of T2D patients, and how it helps make the management of a complex disease more simple. Furthermore, it will discuss how real-world evidence strengthens the safety and efficacy outcomes that were seen in the clinical trials.

Estimated time of Completion: 47 mins

CPD Points: 0.75 Point

PRC Program No: PROG-2022-47773

Linagliptin: 10 Years of Simplicity Course Outline

  • Part I: Real-world evidence of Linagliptin (Trajenta) over the years
  • Part II: Linagliptin (Trajenta) safety profile

PC-PH-105025 / June 2023